Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Dec;54(3):625-33.

The production of human A and B blood group like substances by in vitro maintained second stage Toxocara canis larvae: their presence on the outer larval surfaces and in their excretions/secretions

The production of human A and B blood group like substances by in vitro maintained second stage Toxocara canis larvae: their presence on the outer larval surfaces and in their excretions/secretions

H V Smith et al. Clin Exp Immunol. 1983 Dec.

Abstract

In vitro maintained second stage Toxocara canis larvae do not bind polyclonal anti-human A or B blood group antibodies onto their outer surface at 37 degrees C as detected by indirect fluorescence. When larvae are incubated at 2 degrees C under the same experimental conditions, intense fluorescence over the whole outer surface is observed. Re-incubation of such larvae at 37 degrees C results in a gradual loss of surface fluorescence. This loss is complete after 3 h. The excretions/secretions (ES) of in vitro maintained larvae can neutralize the reactivity of polyclonal anti-human A and B typing antisera against their respective erythrocytic antigens. Rabbits infected with T. canis infective eggs or immunized with ES produce elevated isohaemagglutinin titres against A and B erythrocyte antigens. The presence of epitopes, on the outer surfaces of T. canis larvae and in ES, which cross-react with human ABO blood group antibodies must be borne in mind when larvae or their products are used for the serodiagnosis of human toxocaral larva migrans.

PubMed Disclaimer

References

    1. Pediatrics. 1965 Oct;36(4):523-36 - PubMed
    1. JAMA. 1969 May 19;208(7):1145-8 - PubMed
    1. J Parasitol. 1975 Aug;61(4):781-2 - PubMed
    1. Trans R Soc Trop Med Hyg. 1975;69(3):312-7 - PubMed
    1. Immunology. 1976 Feb;30(2):213-9 - PubMed

Publication types

LinkOut - more resources